Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
Giving to Rush


Liver Transplant Program
Information for Referring Physicians

Headaches

The majority of the liver allograft recipients taking cyclosporine have problems with headaches. These headaches are usually bitemporal and slowly respond to minor analgesics such as aspirin or acetaminophen. Most of these episodes of headaches are a dose-related side effect of cyclosporine. We usually check the 12 hour trough (HPLC) level of cyclosporine, and if it is above low "therapeutic" levels (i.e., above 90 to 150) we lower the daily dosage by 10% weekly until the headaches stop or a dosage of 2-3 mg/kg per day is reached. This rather aggressive reduction of cyclosporine is safely done after six month following liver transplantation, or with serial allograft biopsies (i.e biopsy directed immunosuppression).  For resistant headaches, Fiorinal with and without Elavil have occasionally been helpful.



Rush and the Bulls

Program Overview
First Steps
Waiting List
Living Donor Liver Transplantation
Surgery and Recovery
Personnel
Information for Referring Physicians
Contact Us

Related Topics
    Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | News Room | Clinical Trials
Research At Rush | Nursing At Rush | Work At Rush | Giving to Rush
Disclaimer | Privacy Statement | Site Map

FOR RUSH EMPLOYEES

© Rush University Medical Center, Chicago, Illinois